October 10, 2023
Now available REZZAYO™
REZZAYO™ (rezafungin for injection), for intravenous use, is an echinocandin antifungal indicated in patients 18 years of age or older who have limited or no alternative options for the treatment of candidemia and invasive candidiasis. Approval of this indication is based on limited clinical safety and efficacy data for REZZAYO.
Limitations of Use
REZZAYO has not been studied in patients with endocarditis, osteomyelitis, and meningitis due to Candida.
Please see full prescribing information here.
